SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-030015
Filing Date
2022-03-03
Accepted
2022-03-03 16:15:06
Documents
1
Group Members
CHIN KYU HUHILJIN C&S CO., LTD.ILJIN SEMICONDUCTOR CO., LTD.ILJIN STEEL CO., LTD.SAE KYOUNG HUH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm228317d1_sc13da.htm SC 13D/A 96617
  Complete submission text file 0001104659-22-030015.txt   98283
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88628 | Film No.: 22708892
SIC: 2834 Pharmaceutical Preparations

Mailing Address ILJIN BUILDING, 45 MAPO-DAERO, MAPO-GU SEOUL M5 121-716
Business Address ILJIN BUILDING, 45 MAPO-DAERO, MAPO-GU SEOUL M5 121-716 82-2-707-9742
ILJIN SNT Co., Ltd. (Filed by) CIK: 0001772596 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A